ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy

DNA and Cell Biology

Volumn 28, Issue 3, 2009, Pages 141-150

  Ahluwalia, Tarunveer Singh ^a   Ahuja, Monica ^a   Rai, Taranjit Singh ^a   Kohli, Harbir Singh ^a   Bhansali, Anil ^a   Sud, Kamal ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; RAS PROTEIN;

ADULT; ALLELE; ANGIOTENSIN 2 RECEPTOR TYPE 1 GENE; ANGIOTENSIN CONVERTING ENZYME GENE; ANGIOTENSINOGEN GENE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANGIOTENSINOGEN; ASIA; CASE-CONTROL STUDIES; DIABETIC NEPHROPATHIES; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 62249169286     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0810     Document Type: Article

References (52)

1. Anuradha, S., Radha, V., Deepa, R., Hansen, T., Carstensen, B., Pedersen, O., and Mohan, V. (2005). A prevalence amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. Diabetes Care 28, 2430-2435.
2. Ayodele, O.E., Alebiosu, C.O., and Salako, B.L. (2004). Diabetic nephropathy: a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 96, 1445-1454.
3. Bantis, C., Ivens, K., Kreusser, W., Koch, M., Klein-Vehne, N., Grabensee, B., and Heering, P. (2004). Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am J Nephrol 24, 258-267.
4. Basu, A., Mukherjee, N., Roy, S., Sengupta, S., Banerjee, S., Chakraborty, M., et al. (2003). Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 13, 2277-2290.
5. Boright, A.P., Paterson, A.D., Mirea, L., Bull, S.B., Mowjoodi, A., Scherer, S.W., Zinman, B., and the DCCT/EDIC Research Group (2005). Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 54, 1238-1244.
6. Burns, K.D. (2000). Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 36, 449-467.
7. Chandie Shaw, P.K., Baboe, F., van Es, L.A., van der Vijver, J.C., van de Ree, M.A., de Jonge, N., and Rabelink, T.J. (2006). South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care 29, 1383-1385.
8. Coffey, C.S., Hebert, P.R., Ritchie, M.D., Krumholz, H.M., Gaziano, J.M., Ridker, P.M., et al. (2004). An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics 5, 49-58.
9. Degirmenci, I., Kebapci, N., Basaran, A., Efe, B., Gunes, H.V., Akalin, A., Kurt, H., Urhan, M., and Demirustu, C. (2005). Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract 59, 1137-1142.
10. Doria, A., Onuma, T., Gearin, T., Freire, M.B.S., Warram, J.H., Krolewski, A.S. (1996). Angiotensinogen polymorphism M235T, hypertension and nephropathy in insulin dependent diabetes. Hypertension 27, 1134-1139.
11. Fogarty, D.G., Harron, J.C., Hughes, A.E., Nevin, N.C., Boherty, C.C., and Maxwell, A.P. (1996). A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45, 1204-1208.
12. Fradin, S., Goulet-Salmon, B., Chantepie, M., Grandhomme, F., Morello, R., Jauzac, P., and Reznik, Y. (2002). Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 28, 27-32.
13. Freire, M.B., Ji, L., Onuma, T., Orban, T., Warram, J.H., and Krolewski, A.S. (1998a). Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31, 896-899.
14. Freire, M.B.S., Onuma, T., Orban, T., Warram, J.H., and Krolewski, A.S. (1998b). Gender specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31, 896-899.
15. Gordon, D., Finch, S.J., Nothnagel, M., and Ott, J. (2002). Power and sample size calculations for case-control genetic association tests when errors present: application to single nucleotide polymorphisms. Hum Hered 54, 22-33.
16. Gordon, D., Levenstien, M.A., Finch, S.J., and Ott J. (2003). Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pac Symp Biocomput 490-501. http://psb.stanford.edu/psb-online/proceedings/psb03/.
17. Hadjadj, S., Belloum, R., Bouhanick, B., Gallois, Y., Guilloteau, G., Chatellier, G., Alhenc-Gelas, F., and Marre, M. (2001). Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 12, 541-549.
18. Hadjadj, S., Tarnow, L., Forsblom, C., Kazeem, G., Marre, M., Groop, P.H., et al. (2007). Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol 18, 1284-1291.
19. Harjutsalo, V., Katoh, S., Sarti, C., Tajima, N., and Tuomilehto, J. (2004). Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 53, 2449-2454.
20. Hattersley, A.T., and McCarthy, M.I. (2005). What makes a good genetic association study? Lancet 366, 1315-1323.
21. International Diabetes Federation (IDF) (2007). Diabetes Atlas, 3rd edition. IDF, Brussels, Belgium.
22. Jacobsen, P.K. (2005). Preventing end stage renal disease in diabetic patients-genetic aspect (part I). JRAAS 6, 1-14.
23. Jacobsen, P., Tarnow, L., Carstensen, B., Hovind, P., Poirier, O., and Parving, H.H. (2003). Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14, 2843-2850.
24. Kim, S., and Iwao, W. (2000). Molecular and cellular mechanisms of angiotensin II mediated cardiovascular and renal diseases. Pharmacol Rev 52, 11-34.
25. Kumaramanickavel, G., Sripriya, S., Ramprasad, V.L., Upadyay, N.K., Paul, P.G., and Sharma, T. (2003). Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet 24, 41-48.
26. Lovati, E., Richard, A., Frey, B.M., Frey, F.J., and Ferrari, P. (2001). Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 60, 46-54.
27. Mather, H.M., Chaturvedi, N., Kehely, A.M. (1998). Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 15, 672-677.
28. Moleda, P., Majkowska, L., Safranow, K., Adler, G., and Goracy, I. (2007). Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients. Przegl Lek 64, 134-139.
29. Movva, S., Alluri, R.V., Komandur, S., Vattam, K., Eppa, K., Mukkavali, K.K., Mubigonda, S., Saharia, S., Shastry, J.C., Hasan, Q. (2007). Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 21, 237-241.
30. Neale, B.M., and Sham, P.C. (2004). The future of association studies: gene based analysis and replication. Am J Hum Genet 75, 353-362.
31. Ng, D.P., Placha, G., Choo, S., Chia, K., Warram, J.H., and Krolewski, A.S. (2006). A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55, 2660-2663.
32. Ng, D.P., Tai, B.C., Koh, D., Tan, K.W., and Chia, K.S. (2005). Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48, 1008-1016.
33. Ortega-Pierres, L.E., Gómez García, A., Rodríguez-Ayala, E., Figueroa-Núñez, B., Farias-Rodríguez, V.M., Higareda-Mendoza, A.E., Pardo-Galván, M.A., Cortés-García, J.C., López-Meza, J.E., and Alvarez-Aguilar, C. (2007). Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy. Med Clin (Barc) 129, 6-10.
34. Osawa, N., Koya, D., Araki, S., Uzu, T., Tsunoda, T., Kashiwagi, A., Nakamura, Y., and Maeda, S. (2007). Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 52, 143-151.
35. Prasad, P., Tiwari, A.K., Kumar, K.M., Ammini, A.C., Gupta, A., Gupta, R., et al. (2006). Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 7, 42-50.
36. Rema, M., Saravanan, G., Deepa, R., and Mohan, V. (2002). Familial clustering of diabetic retinopathy in south Indian type 2 diabetic patients. Diabet Med 19, 910-916.
37. Ritchie, M., Hahn, L., Roodi, N., Bailey, R., Dupont, W., Parl, F., and Moore, J. (2001). Multifactor-domensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69, 138-147.
38. Rozen, S., Helen, J., and Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365-386.
39. Ruggenenti, P., Bettinaglio, P., Pinares, F., and Remuzzi, G. (2008). Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 5, 511-525.
40. Schmidt, S., Giessel, R., Bergis, K.H., Strojek, K., Grzeszczak, W., Ganten, D., et al. (1996). Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 11, 1755-1761.
41. Schmidt, S., and Ritz, E. (1997). Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 6, 146-151.
42. Sicree, R., Shaw, J., and Zimmet, P. (2006). Diabetes and impaired glucose tolerance. In Diabetes Atlas, 3rd edition, D. Gan, ed. (International Diabetes Federation, Kortrijik (Heule), Belgium), pp. 15-103.
43. Tarnow, L., Cambien, F., Rossing, P., Nielsen, F.S., Hansen, B.V., Ricard, S., Poirier, O., and Parving, H.H. (1996). Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45, 367-369.
44. Tarnow, L., Gluud, C., and Parving, H.H. (1998). Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 13, 1125-1130.
45. Tomino, Y., Makita, Y., Shike, T., Gohda, T., Haneda, M., Kikkawa, R., Watanabe, T., Baba, T., and Yoshida, H. (1999). Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 82, 139-144.
46. Vijay, V., Snehalatha, C., Shina, K., Lalitha, S., and Ramachandran, A. (1999). Familial aggregation of diabetic kidney disease in type 2 diabetes in south India. Diabetes Res Clin Pract 43, 167-171.
47. Vimaleswaran, K.S., Radha, V., Ghosh, S., Majumder, P.P., Deepa, R., Babu, H.N., Rao, M.R., and Mohan, V. (2005). Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to type 2 diabetes in Asian Indians. Diabet Med 22, 1516-1521.
48. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., and Rothman, N. (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96, 434-442.
49. Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.
50. Ye, S., Dhillon, S., Seear, R., Dunleavey, L., Day, L.B., Bannister, W., Day, I.N., and Simpson, I. (2003). Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis. Heart 89, 1195-1199.
51. Yoshida, H., Kuriyama, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, A., Kubo, H., Kawaguchi, Y., Kon, V., Matsuoka, K., Ichikawa, I., and Sakai, O. (1996). Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50, 657-664.
52. Zychma, M.J., Zukowska-Szczechowska, E., Lacka, B.I., and Grzeszczak, W. (2000). Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes. Nephrol Dial Transplant 15, 1965-1970.